Streetbeat News

Stock Prices

OKUR

The trading halt status was updated at 8:55:00 AM ET, indicating a quotation resumption. This update is crucial for investors tracking the affected securities.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 12:55 pm

ARES

C

CRWD

DECK

On CNBC's 'Halftime Report Final Trades,' experts highlighted Deckers Outdoor Corporation, Citigroup, Ares Management, and CrowdStrike Holdings. Deckers announced a stock split, Citigroup partnered with Apollo for a $25 billion lending program, Ares Management is set to report earnings, and CrowdStrike expanded its Marketplace.

Portfolio Pulse from Avi Kapoor

October 07, 2024 | 12:51 pm

RIME

Algorhythm Holdings (NASDAQ:RIME) saw a significant stock surge after its subsidiary, SemiCab, secured a major contract with a $200 billion global consumer goods company. This contract, starting in October 2024, marks a major milestone for SemiCab, potentially expanding its services and validating its business model.

Portfolio Pulse from Akanksha Bakshi

October 07, 2024 | 12:50 pm

KZR

The FDA has placed a clinical hold on Kezar Life Sciences' mid-stage study of zetomipzomib for lupus nephritis following patient deaths. The company had already suspended the trial based on safety concerns. Kezar's other trials remain unaffected.

Portfolio Pulse from Vandana Singh

October 07, 2024 | 12:50 pm

GLTO

Galecto has completed a strategic review and will now focus on oncology and liver disease. The company has acquired global rights to BRM-1420 from Bridge Medicines, issuing shares as part of the consideration.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 12:49 pm

BMY

CRM

PFE

Pfizer's stock has been underperforming, down nearly 14% over the last year, as demand for its COVID-19 treatments declines. Activist investor Starboard Value has acquired a $1 billion stake in Pfizer, potentially signaling a turning point. Starboard, known for pushing for value, has enlisted former Pfizer executives to help revitalize the company. Despite bearish technical indicators, Starboard's involvement and Pfizer's shift towards oncology could lead to a turnaround.

Portfolio Pulse from Surbhi Jain

October 07, 2024 | 12:42 pm

PRE

Prenetics Global reported a Q2 EPS of $(0.88), beating the estimate of $(0.93), but sales of $5.94M missed the $7.70M estimate. EPS improved from last year, but sales declined.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 12:42 pm

BTCUSD

TSLA

Donald Trump has taken a slight lead over Kamala Harris in election betting odds for the 2024 presidential race, with implications for Bitcoin's price. Elon Musk claims these odds are more accurate than polls. A Trump victory could lead to a significant increase in U.S. national debt and a potential Bitcoin rally.

Portfolio Pulse from Khyathi Dalal

October 07, 2024 | 12:36 pm

XPON

Expion360 has authorized a 1-for-100 reverse stock split, which will consolidate every 100 shares of its common stock into one share. This move is typically aimed at increasing the stock price by reducing the number of shares outstanding.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 12:35 pm

LKCO

Luokung Technology Corp. has regained compliance with Nasdaq's minimum bid price requirement, ensuring its continued listing on the exchange. This development is crucial for maintaining investor confidence and access to capital markets.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 12:30 pm